Congenital deafness gene therapies show promise
Five studies, including at least three with ties to Boston, are using rival gene therapies to treat a hearing disorder caused by mutations in a single gene, called otoferlin.
Stay updated with breaking news from Manny Simons. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Five studies, including at least three with ties to Boston, are using rival gene therapies to treat a hearing disorder caused by mutations in a single gene, called otoferlin.
The genetic treatment targeted a particular kind of congenital deafness and will soon be tried in children who are younger. Aissam Dam, an 11-year-old boy,...
Aissam Dam became the first person to receive gene therapy in the U.S. for congenital deafness after his treatment at the Children’s Hospital of Philadelphia
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
As a city awash in world-class hospitals and biotech firms, we’ve never been ones to rest on our laurels. What’s next for Boston innovators?